213 related articles for article (PubMed ID: 8308694)
1. Mathematical model for the selective deposition of inhaled pharmaceuticals.
Martonen TB
J Pharm Sci; 1993 Dec; 82(12):1191-9. PubMed ID: 8308694
[TBL] [Abstract][Full Text] [Related]
2. Deposition patterns of aerosolized drugs within human lungs: effects of ventilatory parameters.
Martonen TB; Katz IM
Pharm Res; 1993 Jun; 10(6):871-8. PubMed ID: 8321856
[TBL] [Abstract][Full Text] [Related]
3. Mice-to-men comparison of inhaled drug-aerosol deposition and clearance.
Kolanjiyil AV; Kleinstreuer C; Kleinstreuer NC; Pham W; Sadikot RT
Respir Physiol Neurobiol; 2019 Feb; 260():82-94. PubMed ID: 30445230
[TBL] [Abstract][Full Text] [Related]
4. Aerosol deposition as a function of airway disease: cystic fibrosis.
Martonen T; Katz I; Cress W
Pharm Res; 1995 Jan; 12(1):96-102. PubMed ID: 7724494
[TBL] [Abstract][Full Text] [Related]
5. The effects of simulated airway diseases and affected flow distributions on aerosol deposition.
Apiou-Sbirlea G; Katz IM; Martonen TB
Respir Care; 2010 Jun; 55(6):707-18. PubMed ID: 20507653
[TBL] [Abstract][Full Text] [Related]
6. Inhaled Aerosol Distribution in Human Airways: A Scintigraphy-Guided Study in a 3D Printed Model.
Verbanck S; Ghorbaniasl G; Biddiscombe MF; Dragojlovic D; Ricks N; Lacor C; Ilsen B; de Mey J; Schuermans D; Underwood SR; Barnes PJ; Vincken W; Usmani OS
J Aerosol Med Pulm Drug Deliv; 2016 Dec; 29(6):525-533. PubMed ID: 27337643
[TBL] [Abstract][Full Text] [Related]
7. Models of deposition, pharmacokinetics, and intersubject variability in respiratory drug delivery.
Martin AR; Moore CP; Finlay WH
Expert Opin Drug Deliv; 2018 Dec; 15(12):1175-1188. PubMed ID: 30388902
[TBL] [Abstract][Full Text] [Related]
8. The impact of pulmonary diseases on the fate of inhaled medicines--a review.
Wang YB; Watts AB; Peters JI; Williams RO
Int J Pharm; 2014 Jan; 461(1-2):112-28. PubMed ID: 24291124
[TBL] [Abstract][Full Text] [Related]
9. Using helium-oxygen to improve regional deposition of inhaled particles: mechanical principles.
Katz I; Pichelin M; Montesantos S; Majoral C; Martin A; Conway J; Fleming J; Venegas J; Greenblatt E; Caillibotte G
J Aerosol Med Pulm Drug Deliv; 2014 Apr; 27(2):71-80. PubMed ID: 24383961
[TBL] [Abstract][Full Text] [Related]
10. Computationally efficient analysis of particle transport and deposition in a human whole-lung-airway model. Part II: Dry powder inhaler application.
Kolanjiyil AV; Kleinstreuer C; Sadikot RT
Comput Biol Med; 2017 May; 84():247-253. PubMed ID: 27836120
[TBL] [Abstract][Full Text] [Related]
11. Bridging inhaled aerosol dosimetry to physiologically based pharmacokinetic modeling for toxicological assessment: nicotine delivery systems and beyond.
Kolli AR; Kuczaj AK; Martin F; Hayes AW; Peitsch MC; Hoeng J
Crit Rev Toxicol; 2019 Oct; 49(9):725-741. PubMed ID: 31903848
[TBL] [Abstract][Full Text] [Related]
12. Predicted Deposition of E-Cigarette Aerosol in the Human Lungs.
Sosnowski TR; Kramek-Romanowska K
J Aerosol Med Pulm Drug Deliv; 2016 Jun; 29(3):299-309. PubMed ID: 26907696
[TBL] [Abstract][Full Text] [Related]
13. A nonhuman primate aerosol deposition model for toxicological and pharmaceutical studies.
Martonen TB; Katz IM; Musante CJ
Inhal Toxicol; 2001 Apr; 13(4):307-24. PubMed ID: 11295864
[TBL] [Abstract][Full Text] [Related]
14. Factors affecting the deposition of inhaled porous drug particles.
Musante CJ; Schroeter JD; Rosati JA; Crowder TM; Hickey AJ; Martonen TB
J Pharm Sci; 2002 Jul; 91(7):1590-600. PubMed ID: 12115821
[TBL] [Abstract][Full Text] [Related]
15. Aerosol deposition modeling using ACSL.
Carpenter RL
Drug Chem Toxicol; 1999 Feb; 22(1):73-90. PubMed ID: 10189572
[TBL] [Abstract][Full Text] [Related]
16. Calculation of hygroscopic particle deposition in the human lung.
Winkler-Heil R; Ferron G; Hofmann W
Inhal Toxicol; 2014 Feb; 26(3):193-206. PubMed ID: 24517842
[TBL] [Abstract][Full Text] [Related]
17. Substance deposition assessment in obstructed pulmonary system through numerical characterization of airflow and inhaled particles attributes.
Lalas A; Nousias S; Kikidis D; Lalos A; Arvanitis G; Sougles C; Moustakas K; Votis K; Verbanck S; Usmani O; Tzovaras D
BMC Med Inform Decis Mak; 2017 Dec; 17(Suppl 3):173. PubMed ID: 29297393
[TBL] [Abstract][Full Text] [Related]
18. Factors affecting the deposition of aerosolized insulin.
Katz IM; Schroeter JD; Martonen TB
Diabetes Technol Ther; 2001; 3(3):387-97. PubMed ID: 11762517
[TBL] [Abstract][Full Text] [Related]
19. Comparison of stochastic lung deposition fractions with experimental data.
Majid H; Hofmann W; Winkler-Heil R
Ann Occup Hyg; 2012 Apr; 56(3):278-91. PubMed ID: 22104318
[TBL] [Abstract][Full Text] [Related]
20. Predictive models for deposition of inhaled diesel exhaust particles in humans and laboratory species.
Yu CP; Xu GB
Res Rep Health Eff Inst; 1987; (10):3-22. PubMed ID: 2478161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
